EIPH

Compounding Pharmacy, Supplier Sued For $6 Million Over Viagra Positives

Quarter horse trainer John Stinebaugh, suspended 16 years and fined $40,000 after four of his horses tested positive for the active ingredient in human erectile dysfunction drug Viagra at Ruidoso Downs in New Mexico, is suing a Texas compounding pharmacy and one of its suppliers for $6 million, alleging negligence in the manufacture of a […]

Continue reading
Keeping Racehorses In Top Condition Is A Team Effort

To keep a racehorse in peak condition, it truly takes a team of people. From the trainer and owner who are managing and paying for the horse, to the veterinarian, groom, rider, farrier, and others who get to know the horse on an intimate level, it takes a group effort to make sure every need […]

Continue reading
New York Horsemen’s Election: ‘Truthiness’ and the Truth

When it comes to the ongoing election for president of the New York Thoroughbred Horsemen’s Association, there is “truth” and there is “truthiness.” The truthiness of the election, the agenda pushed by allies of current NYTHA president Rick Violette, is that the only issue that matters is Lasix, the race-day medication used to treat exercise-induced […]

Continue reading
Jockey Club: EIPH Study Supports Call for Race-Day Medication Ban

Editor’s Note: The Jockey Club believes that horses should compete only when they are free from the influence of medication. The following essay, written by Matt Iuliano, the executive vice president and executive director of The Jockey Club, provides insights into a recent study pertaining to exercise-induced pulmonary hemorrhage (EIPH) and long-term racing performance. A […]

Continue reading
Study Finds that Racing Careers Not Shortened by EIPH

A recently completed study of Thoroughbred race horses has shown that there is no difference in the length of racing careers between horses that experienced some level of exercise-induced pulmonary hemorrhage (EIPH) and those that did not. The Blood-Horse reports that the study, which took place over a five-year period, examined 822 geldings that were […]

Continue reading
TOBA, Flair Sponsor Informative Seminar on EIPH Treatment

The makers of FLAIR Nasal Strips, in partnership with the Thoroughbred Owners and Breeders Association, sponsored a seminar at Keeneland April 9 to discuss the treatment of exercise-induced pulmonary hemorrhage (EIPH) by non-medicinal means. The Blood-Horse reported that Dr. Jim Chiapetta, one of the co-inventors of the FLAIR strips, discussed that while there currently is […]

Continue reading
The Breeders’ Cup Forum: Lasix – An International Veterinary Perspective

Brian Stewart is the head of Equine Welfare and Veterinary Services for Racing Victoria, the primary authority overseeing horse racing in the region of Australia that includes Melbourne.  Formerly a private practitioner in Caulfield, Stewart was the head of Veterinary Regulation and International Liaison for the Hong Kong Jockey Club from 2002-2011. He has served […]

Continue reading
The Breeders’ Cup Forum: Lasix – A Racetrack Practitioner’s Perspective

Dr. Don Shields has been a Southern California racetrack practitioner for more than 25 years since his graduation from the University of California-Davis School of Veterinary Medicine in 1987. While he has specialty training in diagnostic ultrasound and has performed numerous stem-cell and platelet rich plasma treatments to injured tendons and ligaments of horse, Dr. […]

Continue reading
California panel: ‘The only treatment to decrease EIPH severity is furosemide’

Thoroughbred Owners of California representatives joined nationally prominent owners and trainers to hear a panel of international scientists discuss Exercise Induced Pulmonary Hemorrhage (EIPH) and other critical Thoroughbred injuries in Beverly Hills on Jan. 18. Following the day-long forum, the distinguished panel issued the following consensus statement on EIPH: Exercise Induced Pulmonary Hemorrhage (E.I.P.H.) is a […]

Continue reading
Would medication ban be form of class warfare?

(Editor’s Note: The following commentary is from Steve Montemarano, a board member of the Ohio Thoroughbred Fund and an equine sales executive for Merck.) Eliminating race day medication has little to do with protecting horse health, improving the breed, or making Thoroughbred racing a better sport. In reality it is a veiled attempt by elitists […]

Continue reading
Twitter Twitter
Paulick Report on Instagram